Loading company…
Malcisbo AG develops vaccines against bacterial infections in poultry and swine, based in Schlieren, Switzerland.
Malcisbo AG develops vaccines against bacterial infections in livestock, particularly poultry and swine, using a glycoengineering platform. Its target pathogens include Campylobacter and Actinobacillus pleuropneumonia, and it sells to farms and livestock producers through distributors. Founded in 2010 and based in Schlieren, Switzerland, the company is led by CEOs Bruno Oesch and Lino Camponovo, and it received funding from Redalpine Venture Partners in September 2011.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in